GCM
AZN icon

Gallacher Capital Management’s AstraZeneca AZN Stock Holding History

Gallacher Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Sell
2,120
-1,923
-48% -$362K 0.23% 149
2026
Q1 		$797K Sell
4,043
-4
-0.1% -$771 0.31% 91
2025
Q4 		$744K Sell
4,047
-5
-0.1% -$877 0.29% 92
2025
Q3 		$622K Buy
4,052
+786
+24% +$119K 0.25% 132
2025
Q2 		$456K Buy
3,266
+289
+10% +$40.5K 0.21% 137
2025
Q1 		$438K Buy
2,977
+166
+6% +$24K 0.21% 135
2024
Q4 		$368K Buy
2,811
+39
+1% +$5.46K 0.18% 151
2024
Q3 		$432K Buy
2,772
+205
+8% +$33.1K 0.2% 131
2024
Q2 		$400K Sell
2,567
-149
-5% -$22.4K 0.21% 126
2024
Q1 		$368K Buy
2,716
+75
+3% +$9.93K 0.19% 145
2023
Q4 		$356K Buy
2,641
+21
+0.8% +$2.73K 0.2% 130
2023
Q3 		$355K Buy
2,620
+221
+9% +$30.2K 0.22% 107
2023
Q2 		$343K Buy
2,399
+154
+7% +$22.7K 0.2% 142
2023
Q1 		$312K Buy
2,245
+186
+9% +$25K 0.19% 152
2022
Q4 		$279K Buy
+2,059
New +$258K 0.17% 151

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Gallacher Capital Management's AZN Position: Q2 2026 in Review

Gallacher Capital Management reduced its AstraZeneca (AZN) stake by 48% in Q2 2026, selling an estimated $362K and leaving 2,120 shares worth $402K. The position accounts for 0.23% of the portfolio, ranked #149.

Gallacher Capital Management first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $797K in Q1 2026. 383 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Gallacher Capital Management held 2,120 shares of AstraZeneca worth $402K as of Q2 2026.
  • Gallacher Capital Management sold 1,923 AstraZeneca shares in Q2 2026, an estimated $362K.
  • AstraZeneca made up 0.23% of Gallacher Capital Management's portfolio in Q2 2026, its #149 holding.
  • Gallacher Capital Management first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
  • Gallacher Capital Management's AstraZeneca position peaked at $797K in Q1 2026.
  • 383 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.